(R)-Zunsemetinib

(R)-Zunsemetinib structure	Common Name	(R)-Zunsemetinib
	CAS Number	1640282-44-5	Molecular Weight	513.92
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₅H₂₂ClF₂N₅O₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of (R)-Zunsemetinib

(R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].

Name	(R)-Zunsemetinib

Description	(R)-Zunsemetinib is the inactive isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
References	[1]. Zunsemetinib (ATI-450) – Investigational oral MK2 pathway inhibitor [2]. Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine [3]. Wang C, et al. Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med. 2018;215(5):1315-1325.

Description

Related Catalog

Signaling Pathways >> Others >> Others

Research Areas >> Inflammation/Immunology

References

[1]. Zunsemetinib (ATI-450) – Investigational oral MK2 pathway inhibitor

[2]. Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in Journal of Experimental Medicine

[3]. Wang C, et al. Selective inhibition of the p38α MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals. J Exp Med. 2018;215(5):1315-1325.

Molecular Formula	C₂₅H₂₂ClF₂N₅O₃
Molecular Weight	513.92

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

(R)-Zunsemetinib

Use of (R)-Zunsemetinib

Names

(R)-Zunsemetinib Biological Activity

Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.